Revelation Biosciences, Inc. (REVB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 26.96K | 0 | 0 | 0 | 37.57K | 0 | 0 |
| Revenue Growth % | - | -100% | - | - | - | -28.24% | - | - | - | - | - | - |
| Cost of Goods Sold | 7.2K | 0 | 0 | 0 | 0 | 13.48K | 7.22K | 7.22K | 6.26K | 18.79K | 6.26K | 6.26K |
| COGS % of Revenue | - | - | - | - | - | 50% | - | - | - | 50% | - | - |
| Gross Profit | -7.2K | 0 | 0 | 0 | 0 | 13.48K | -7.22K | -7.22K | -6.26K | 18.79K | -6.26K | -6.26K |
| Gross Margin % | - | - | - | - | - | 50% | - | - | - | 50% | - | - |
| Gross Profit Growth % | - | -100% | 100% | 100% | 100% | -28.24% | -15.3% | -15.3% | 0.02% | 400.02% | 0% | 0% |
| Operating Expenses | 3.09M | 2.57M | 1.94M | 2.46M | 2.09M | 1.75M | 1.8M | 2.52M | 1.9M | 2.33M | 2.78M | 1.93M |
| OpEx % of Revenue | - | - | - | - | - | 6504.55% | - | - | - | 6190.16% | - | - |
| Selling, General & Admin | 1.71M | 1.61M | 1.02M | 1.14M | 1.24M | 1.15M | 965.71K | 1.13M | 1.18M | 1.27M | 1.13M | 1.02M |
| SG&A % of Revenue | - | - | - | - | - | 4258.95% | - | - | - | 3369.1% | - | - |
| Research & Development | 1.38M | 964.19K | 922.86K | 1.32M | 858.83K | 605.5K | 830.98K | 1.39M | 717.58K | 1.06M | 1.65M | 909.28K |
| R&D % of Revenue | - | - | - | - | - | 2245.6% | - | - | - | 2821.06% | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.09M | -2.57M | -1.94M | -2.46M | -2.09M | -1.75M | -1.8M | -2.52M | -1.9M | -2.33M | -2.78M | -1.93M |
| Operating Margin % | - | - | - | - | - | -6504.55% | - | - | - | -6190.16% | - | - |
| Operating Income Growth % | -47.61% | -46.62% | -8.14% | 2.43% | -10.14% | 24.59% | 35.32% | -30.49% | -17.43% | -90.91% | -131.59% | -3.9% |
| EBITDA | -3.09M | -2.57M | -1.94M | -2.45M | -2.09M | -1.75M | -1.79M | -2.52M | -1.9M | -2.32M | -2.77M | -1.93M |
| EBITDA Margin % | - | - | - | - | - | -6477.77% | - | - | - | -6173.49% | - | - |
| EBITDA Growth % | -47.78% | -46.89% | -8.2% | 2.43% | -10.12% | 24.7% | 35.44% | -30.54% | -17.49% | -91.38% | -132.29% | -3.92% |
| D&A (Non-Cash Add-back) | 7.2K | 5.85K | 6.76K | 7.22K | 7.22K | 7.22K | 7.22K | 7.22K | 6.26K | 6.26K | 6.26K | 6.26K |
| EBIT | -3.09M | -2.57M | -1.94M | -2.46M | -2.09M | -1.75M | -1.8M | -2.52M | -1.9M | -2.33M | -2.78M | -1.93M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 83.45K | 60.58K | 35.84K | 16.85K | 43.9K | 28.17K | -444.88K | -5.87M | -779.29K | 122.99K | 149.52K | 484.86K |
| Pretax Income | -3.01M | -2.51M | -1.91M | -2.44M | -2.05M | -1.73M | -2.24M | -8.39M | -2.68M | -2.2M | -2.63M | -1.45M |
| Pretax Margin % | - | - | - | - | - | -6400.09% | - | - | - | -5862.84% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.01M | -2.51M | -1.91M | -2.44M | -2.05M | -1.73M | -2.24M | -8.39M | -2.68M | -2.2M | -2.63M | -1.45M |
| Net Margin % | - | - | - | - | - | -6400.09% | - | - | - | -5862.84% | - | - |
| Net Income Growth % | -46.71% | -45.5% | 14.92% | 70.86% | 23.51% | 21.66% | 14.72% | -479.34% | -143.54% | -82.42% | -124.51% | 21.07% |
| Net Income (Continuing) | -3.01M | -2.51M | -1.91M | -2.44M | -2.05M | -1.73M | -2.24M | -8.39M | -2.68M | -2.2M | -2.63M | -1.45M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.71 | -1.65 | -1.77 | -7.01 | -2.11 | -4.98 | -13.38 | -82.09 | -39.37 | -133.24 | -200.34 | -119.60 |
| EPS Growth % | -28.44% | 66.87% | 86.77% | 91.46% | 94.64% | 96.26% | 93.32% | 31.36% | -104.18% | 84.3% | 78.55% | 94.15% |
| EPS (Basic) | -2.71 | -1.65 | -1.77 | -7.01 | -2.11 | -4.98 | -13.38 | -82.09 | -39.37 | -133.24 | -200.34 | -119.60 |
| Diluted Shares Outstanding | 3.21M | 620.8K | 2.64M | 802.67K | 971.31K | 346.5K | 167.5K | 102.2K | 68.11K | 16.53K | 13.12K | 12.11K |
| Basic Shares Outstanding | 3.21M | 620.8K | 2.64M | 802.67K | 971.31K | 346.5K | 167.5K | 102.2K | 68.11K | 16.53K | 13.12K | 12.11K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |